These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 38003608)

  • 1. A Putative Role for TRPC6 in Immune-Mediated Kidney Injury.
    't Hart DC; van der Vlag J; Nijenhuis T
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases.
    Ilatovskaya DV; Staruschenko A
    Am J Physiol Renal Physiol; 2015 Sep; 309(5):F393-7. PubMed ID: 26084930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPC Channels in Proteinuric Kidney Diseases.
    Hall G; Wang L; Spurney RF
    Cells; 2019 Dec; 9(1):. PubMed ID: 31877991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposing Riociguat to Target a Novel Paracrine Nitric Oxide-TRPC6 Pathway to Prevent Podocyte Injury.
    't Hart D; Li J; van der Vlag J; Nijenhuis T
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
    Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
    J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II has acute effects on TRPC6 channels in podocytes of freshly isolated glomeruli.
    Ilatovskaya DV; Palygin O; Chubinskiy-Nadezhdin V; Negulyaev YA; Ma R; Birnbaumer L; Staruschenko A
    Kidney Int; 2014 Sep; 86(3):506-14. PubMed ID: 24646854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Ma R; Xu Y; Zhou H; Zhang D; Yao D; Song L; Liu Y
    Mol Med Rep; 2019 Mar; 19(3):2421-2430. PubMed ID: 30664212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical transient receptor potential channel (TRPC)3 and TRPC6 associate with large-conductance Ca2+-activated K+ (BKCa) channels: role in BKCa trafficking to the surface of cultured podocytes.
    Kim EY; Alvarez-Baron CP; Dryer SE
    Mol Pharmacol; 2009 Mar; 75(3):466-77. PubMed ID: 19052171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canonical Transient Receptor Potential 6 Channel: A New Target of Reactive Oxygen Species in Renal Physiology and Pathology.
    Ma R; Chaudhari S; Li W
    Antioxid Redox Signal; 2016 Nov; 25(13):732-748. PubMed ID: 26937558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.
    Dryer SE; Reiser J
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F689-701. PubMed ID: 20685822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.
    Wang Q; Tian X; Wang Y; Wang Y; Li J; Zhao T; Li P
    J Diabetes Res; 2020; 2020():6897390. PubMed ID: 31998809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.
    Yu J; Zhu C; Yin J; Yu D; Wan F; Tang X; Jiang X
    Drug Des Devel Ther; 2020; 14():361-370. PubMed ID: 32095070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of TRPC6 in oxidative stress-induced podocyte ischemic injury.
    Zhao B; Yang H; Zhang R; Sun H; Liao C; Xu J; Meng K; Jiao J
    Biochem Biophys Res Commun; 2015 May; 461(2):413-20. PubMed ID: 25896763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.
    Li Z; Xu J; Xu P; Liu S; Yang Z
    Cell Prolif; 2013 Feb; 46(1):76-85. PubMed ID: 23294354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin prevents hypoxia-induced podocyte injury by regulating the ZEB2/TG2 axis.
    Kolligundla LP; Kavvuri R; Singh AK; Mukhi D; Pasupulati AK
    Nephrology (Carlton); 2023 Jan; 28(1):60-71. PubMed ID: 36217796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P; Canales CP; Kairath P; Carmona-Mora P; Molina J; Carpio JD; Ruiz P; Mezzano SA; Li J; Wei C; Reiser J; Young JI; Walz K
    PLoS One; 2010 Sep; 5(9):e12859. PubMed ID: 20877463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.